Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Research & Development: 2024-2025

Historic Research & Development for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $67.9 million.

  • Kura Oncology's Research & Development rose 62.83% to $67.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $238.9 million, marking a year-over-year change of. This contributed to the annual value of $170.0 million for FY2024, which is 47.50% up from last year.
  • Per Kura Oncology's latest filing, its Research & Development stood at $67.9 million for Q3 2025, which was up 8.16% from $62.8 million recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Research & Development ranged from a high of $67.9 million in Q3 2025 and a low of $36.3 million during Q1 2024.
  • For the 2-year period, Kura Oncology's Research & Development averaged around $50.9 million, with its median value being $52.3 million (2024).
  • Data for Kura Oncology's Research & Development shows a peak YoY skyrocketed of 62.83% (in 2025) over the last 5 years.
  • Over the past 2 years, Kura Oncology's Research & Development (Quarterly) stood at $52.3 million in 2024, then surged by 62.83% to $67.9 million in 2025.
  • Its last three reported values are $67.9 million in Q3 2025, $62.8 million for Q2 2025, and $56.0 million during Q1 2025.